ATP-citrate lyase: A mini-review

Biochemical and Biophysical Research Communications

Volumn 422, Issue 1, 2012, Pages 1-4

  Chypre, Melanie ^a   Zaidi, Nousheen ^a,b   Smans, Karine ^a  

^a JANSSEN RESEARCH AND DEVELOPMENT   (Belgium)

^b KU Leuven   (Belgium)

Author keywords

ATP citrate lyase; De novo lipid synthesis; Fatty acid synthesis; Mevalonate pathway

Indexed keywords

2,2 DIFLUOROCITRATE; ADENOSINE TRIPHOSPHATE CITRATE LYASE; HYDROXYCITRIC ACID; LYASE INHIBITOR; RADICICOL; SB 204990; UNCLASSIFIED DRUG;

CELL GROWTH; CELL SURVIVAL; CELLULAR DISTRIBUTION; CRYSTAL STRUCTURE; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME MECHANISM; FETUS DEVELOPMENT; FETUS GROWTH; GENE CONTROL; HUMAN; METABOLIC DISORDER; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SHORT SURVEY; TISSUE DISTRIBUTION; TUMOR CELL;

ANIMALS; ATP CITRATE (PRO-S)-LYASE; CELL PROLIFERATION; CRYSTALLOGRAPHY, X-RAY; FETAL DEVELOPMENT; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; METABOLIC DISEASES; NEOPLASMS; TISSUE DISTRIBUTION;

EID: 84861455446     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.04.144     Document Type: Short Survey

References (40)

1. Watson J.A., Fang M., Lowenstein J.M. Tricarballylate and hydroxycitrate: substrate and inhibitor of ATP:citrate oxaloacetate lyase. Arch. Biochem. Biophys. 1969, 135:209-217.
2. Wang Q., Li S., Jiang L., Zhou Y., Li Z., Shao M., Li W., Liu Y. Deficiency in hepatic ATP-citrate lyase affects VLDL-triglyceride mobilization and liver fatty acid composition in mice. J. Lipid Res. 2010, 51:2516-2526.
3. Chu K.Y., Lin Y., Hendel A., Kulpa J.E., Brownsey R.W., Johnson J.D. ATP-citrate lyase reduction mediates palmitate-induced apoptosis in pancreatic beta cells. J. Biol. Chem. 2010, 285:32606-32615.
4. Fukuda H., Katsurada A., Iritani N. Effects of nutrients and hormones on gene expression of ATP citrate-lyase in rat liver. Eur. J. Biochem. 1992, 209:217-222.
5. MacDonald M.J., Smith A.D., Hasan N.M., Sabat G., Fahien L.A. Feasibility of pathways for transfer of acyl groups from mitochondria to the cytosol to form short chain acyl-CoAs in the pancreatic beta cell. J. Biol. Chem. 2007, 282:30596-30606.
6. Linn T.C., Srere P.A. Binding of ATP citrate lyase to the microsomal fraction of rat liver. J. Biol. Chem. 1984, 259:13379-13384.
7. Wellen K.E., Hatzivassiliou G., Sachdeva U.M., Bui T.V., Cross J.R., Thompson C.B. ATP-citrate lyase links cellular metabolism to histone acetylation. Science 2009, 324:1076-1080.
8. Paine P.L., Moore L.C., Horowitz S.B. Nuclear envelope permeability. Nature 1975, 254:109-114.
9. Singh M., Richards E.G., Mukherjee A., Srere P.A. Structure of ATP citrate lyase from rat liver. Physicochemical studies and proteolytic modification. J. Biol. Chem. 1976, 251:5242-5250.
10. Elshourbagy N.A., Near J.C., Kmetz P.J., Sathe G.M., Southan C., Strickler J.E., Gross M., Young J.F., Wells T.N., Groot P.H. Rat ATP citrate-lyase. Molecular cloning and sequence analysis of a full-length cDNA and mRNA abundance as a function of diet, organ, and age. J. Biol. Chem. 1990, 265:1430-1435.
11. Sun T., Hayakawa K., Bateman K.S., Fraser M.E. Identification of the citrate-binding site of human ATP-citrate lyase using X-ray crystallography. J. Biol. Chem. 2010, 285:27418-27428.
12. Sun T., Hayakawa K., Fraser M.E. ADP-Mg2+ bound to the ATP-grasp domain of ATP-citrate lyase Acta Crystallogr. Sect. F: Struct. Biol. Cryst. Commun. 2011, 67:1168-1172.
13. Linn T.C., Srere P.A. Identification of ATP citrate lyase as a phosphoprotein. J. Biol. Chem. 1979, 254:1691-1698.
14. Hatzivassiliou G., Zhao F., Bauer D.E., Andreadis C., Shaw A.N., Dhanak D., Hingorani S.R., Tuveson D.A., Thompson C.B. ATP citrate lyase inhibition can suppress tumor cell growth. Cancer Cell 2005, 8:311-321.
15. Srere P.A. The citrate cleavage enzyme. I. Distribution and purification. J. Biol. Chem. 1959, 234:2544-2547.
16. Ma Z., Chu C.H., Cheng D. A novel direct homogeneous assay for ATP citrate lyase. J. Lipid Res. 2009, 50:2131-2135.
17. Abramson H.N. The lipogenesis pathway as a cancer target. J. Med. Chem. 2011, 54:5615-5638.
18. Bauer D.E., Hatzivassiliou G., Zhao F., Andreadis C., Thompson C.B. ATP citrate lyase is an important component of cell growth and transformation. Oncogene 2005, 24:6314-6322.
19. Sato R., Okamoto A., Inoue J., Miyamoto W., Sakai Y., Emoto N., Shimano H., Maeda M. Transcriptional regulation of the ATP citrate-lyase gene by sterol regulatory element-binding proteins. J. Biol. Chem. 2000, 275:12497-12502.
20. Migita T., Narita T., Nomura K., Miyagi E., Inazuka F., Matsuura M., Ushijima M., Mashima T., Seimiya H., Satoh Y., Okumura S., Nakagawa K., Ishikawa Y. ATP citrate lyase: activation and therapeutic implications in non-small cell lung cancer. Cancer Res. 2008, 68:8547-8554.
21. Lord K.A., Wang X.M., Simmons S.J., Bruckner R.C., Loscig J., O'Connor B., Bentley R., Smallwood A., Chadwick C.C., Stevis P.E., Ciccarelli R.B. Variant cDNA sequences of human ATP:citrate lyase: cloning, expression, and purification from baculovirus-infected insect cells. Protein Expr. Purif. 1997, 9:133-141.
22. Wagner P.D., Vu N.D. Phosphorylation of ATP-citrate lyase by nucleoside diphosphate kinase. J. Biol. Chem. 1995, 270:21758-21764.
23. Pierce M.W., Palmer J.L., Keutmann H.T., Avruch J. ATP-citrate lyase. Structure of a tryptic peptide containing the phosphorylation site directed by glucagon and the cAMP-dependent protein kinase. J. Biol. Chem. 1981, 256:8867-8870.
24. Mashima T., Seimiya H., Tsuruo T. De novo fatty-acid synthesis and related pathways as molecular targets for cancer therapy. Br. J. Cancer 2009, 100:1369-1372.
25. Joo J.H., Jetten A.M. Molecular mechanisms involved in farnesol-induced apoptosis. Cancer Lett. 2010, 287:123-135.
26. Metallo C.M., Gameiro P.A., Bell E.L., Mattaini K.R., Yang J., Hiller K., Jewell C.M., Johnson Z.R., Irvine D.J., Guarente L., Kelleher J.K., Vander Heiden M.G., Iliopoulos O., Stephanopoulos G. Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia. Nature 2011.
27. Mullen A.R., Wheaton W.W., Jin E.S., Chen P.H., Sullivan L.B., Cheng T., Yang Y., Linehan W.M., Chandel N.S., Deberardinis R.J. Reductive carboxylation supports growth in tumour cells with defective mitochondria. Nature 2011.
28. Beigneux A.P., Kosinski C., Gavino B., Horton J.D., Skarnes W.C., Young S.G. ATP-citrate lyase deficiency in the mouse. J. Biol. Chem. 2004, 279:9557-9564.
29. Yancy H.F., Mason J.A., Peters S., Thompson C.E., Littleton G.K., Jett M., Day A.A. Metastatic progression and gene expression between breast cancer cell lines from African, American and Caucasian women. J. Carcinog. 2007, 6:8.
30. Yahagi N., Shimano H., Hasegawa K., Ohashi K., Matsuzaka T., Najima Y., Sekiya M., Tomita S., Okazaki H., Tamura Y., Iizuka Y., Nagai R., Ishibashi S., Kadowaki T., Makuuchi M., Ohnishi S., Osuga J., Yamada N. Co-ordinate activation of lipogenic enzymes in hepatocellular carcinoma. Eur. J. Cancer 2005, 41:1316-1322.
31. Varis A., Wolf M., Monni O., Vakkari M.L., Kokkola A., Moskaluk C., Frierson H., Powell S.M., Knuutila S., Kallioniemi A., El-Rifai W. Targets of gene amplification and overexpression at 17q in gastric cancer. Cancer Res. 2002, 62:2625-2629.
32. Turyn J., Schlichtholz B., Dettlaff-Pokora A., Presler M., Goyke E., Matuszewski M., Kmiec Z., Krajka K., Swierczynski J. Increased activity of glycerol 3-phosphate dehydrogenase and other lipogenic enzymes in human bladder cancer. Horm. Metab. Res. 2003, 35:565-569.
33. Szutowicz A., Kwiatkowski J., Angielski S. Lipogenetic and glycolytic enzyme activities in carcinoma and nonmalignant diseases of the human breast. Br. J. Cancer 1979, 39:681-687.
34. 13C NMR spectroscopy. Magn. Reson. Med. 1988, 7:384-411.
35. Guay C., Madiraju S.R., Aumais A., Joly E., Prentki M. A role for ATP-citrate lyase, malic enzyme, and pyruvate/citrate cycling in glucose-induced insulin secretion. J. Biol. Chem. 2007, 282:35657-35665.
36. MacDonald M.J., Longacre M.J., Langberg E.C., Tibell A., Kendrick M.A., Fukao T., Ostenson C.G. Decreased levels of metabolic enzymes in pancreatic islets of patients with type 2 diabetes. Diabetologia 2009, 52:1087-1091.
37. Chu K.Y., Lin Y., Hendel A., Kulpa J.E., Brownsey R.W., Johnson J.D. ATP-citrate lyase reduction mediates palmitate-induced apoptosis in pancreatic beta cells. J. Biol. Chem. 2010, 285:32606-32615.
38. Pearce N.J., Yates J.W., Berkhout T.A., Jackson B., Tew D., Boyd H., Camilleri P., Sweeney P., Gribble A.D., Shaw A., Groot P.H. The role of ATP citrate-lyase in the metabolic regulation of plasma lipids. Hypolipidaemic effects of SB-204990, a lactone prodrug of the potent ATP citrate-lyase inhibitor SB-201076. Biochem. J. 1998, 334(Pt 1):113-119.
39. Wang Q., Jiang L., Wang J., Li S., Yu Y., You J., Zeng R., Gao X., Rui L., Li W., Liu Y. Abrogation of hepatic ATP-citrate lyase protects against fatty liver and ameliorates hyperglycemia in leptin receptor-deficient mice. Hepatology 2009, 49:1166-1175.
40. Melnick J.Z., Srere P.A., Elshourbagy N.A., Moe O.W., Preisig P.A., Alpern R.J. Adenosine triphosphate citrate lyase mediates hypocitraturia in rats. J. Clin. Invest. 1996, 98:2381-2387.